Cargando…
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays
The SARS-CoV-2 pandemic has challenged molecular microbiology laboratories to quickly implement and validate diagnostic assays and to expand testing capacity in a short timeframe. Multiple molecular diagnostic methods received FDA emergency use authorization (EUA) and were promptly validated for use...
Autores principales: | Mostafa, Heba H., Hardick, Justin, Morehead, Elizabeth, Miller, Jo-Anne, Gaydos, Charlotte A., Manabe, Yukari C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405824/ https://www.ncbi.nlm.nih.gov/pubmed/32777761 http://dx.doi.org/10.1016/j.jcv.2020.104578 |
Ejemplares similares
-
Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron
por: Hardick, Justin, et al.
Publicado: (2022) -
Comparing the analytical performance of three SARS-CoV-2 molecular diagnostic assays
por: Uhteg, Katharine, et al.
Publicado: (2020) -
Prospective comparison of RT-PCR/ESI-MS to Prodesse ProFlu Plus and Cepheid GenXpert for the detection of Influenza A and B viruses
por: Hardick, Justin, et al.
Publicado: (2015) -
Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients
por: Douet, Tiphaine, et al.
Publicado: (2019) -
Low-Cost 3D Printers Enable High-Quality and Automated Sample Preparation and Molecular Detection
por: Chan, Kamfai, et al.
Publicado: (2016)